Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents

E-ISSN： 1875-5607|18|4|296-309

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.18, Iss.4, 2018-01, pp. : 296-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite

CA 1 A 2 X-competitive inhibitors of farnesyltransferase as anti-cancer agents

By Omer C.A. Kohl N.E.

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery

Current Pharmaceutical Design, Vol. 15, Iss. 33, 2009-11 ,pp. : 3839-3843

Bentham Science Publishers

Access to resources Recommend Favorite

Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A)

Current Drug Delivery, Vol. 15, Iss. 2, 2018-02 ,pp. : 286-295

Bentham Science Publishers

Access to resources Recommend Favorite